Meprednisone
Chemical compound
- H02AB15 (WHO)
- (16β)-17,21-dihydroxy-16-methylpregna-1,4-diene-3,11,20-trione
- 1247-42-3 N
- 5284587
- 4447637 Y
- 67U96J8P35
- D06673 Y
- CHEBI:135573
- ChEMBL1201148 N
- DTXSID8023260
- Interactive image
- O=C(CO)[C@@]3(O)[C@@H](C)C[C@H]2[C@@H]4CC\C1=C\C(=O)\C=C/[C@]1(C)[C@H]4C(=O)C[C@@]23C
InChI
- InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,12,15-16,19,23,27H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19+,20-,21-,22-/m0/s1 Y
- Key:PIDANAQULIKBQS-RNUIGHNZSA-N Y
Meprednisone is a glucocorticoid. It is a methylated derivative of prednisone.[1]
See also
- Glucocorticoid
- Corticosteroid
References
- ^ Elks J (1990). "Meprednisone". The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Dordrecht: Springer. p. 418. ISBN 978-1-4757-2085-3.
- v
- t
- e
Natural | |
---|---|
Synthetic |
|
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e